Ariel M. Rubinstein

1.8k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Ariel M. Rubinstein is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Ariel M. Rubinstein has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Cell Biology and 6 papers in Surgery. Recurrent topics in Ariel M. Rubinstein's work include Fibroblast Growth Factor Research (13 papers), Proteoglycans and glycosaminoglycans research (13 papers) and Pancreatic function and diabetes (4 papers). Ariel M. Rubinstein is often cited by papers focused on Fibroblast Growth Factor Research (13 papers), Proteoglycans and glycosaminoglycans research (13 papers) and Pancreatic function and diabetes (4 papers). Ariel M. Rubinstein collaborates with scholars based in Israel, United States and Netherlands. Ariel M. Rubinstein's co-authors include Michael Elkin, Amichay Meirovitz, Rachel Goldberg, Gabriel Nussbaum, Stuart L. Fischman, Esther Hermano, Israël Vlodavsky, Eyal Zcharia, Johan van der Vlag and Jin‐Ping Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Ariel M. Rubinstein

32 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model

2015 328 citations Ariel M. Rubinstein, Michael Elkin et al. profile →

Peers

Ariel M. Rubinstein

PERIO

ONCOL

SURGE

Kisho Ono Japan

Isabelle Masouyé Switzerland

Jennifer L. Hand United States

H Tanzawa Japan

Christopher Hull United States

Daisy I. Picavet Netherlands

Jun Saegusa Japan

Teruki Yanagi Japan

Alfredo Ribeiro‐Silva Brazil

Paolo Fabbri Italy

Kisho Ono Japan

Ariel M. Rubinstein

860 ×1.4

107 ×0.2

98 ×0.5

PERIO

290 ×1.7

ONCOL

111 ×0.7

SURGE

Citations per year, relative to Ariel M. Rubinstein Ariel M. Rubinstein (= 1×) peers Kisho Ono

Countries citing papers authored by Ariel M. Rubinstein

Since Specialization

Citations

This map shows the geographic impact of Ariel M. Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel M. Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel M. Rubinstein more than expected).

Fields of papers citing papers by Ariel M. Rubinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel M. Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel M. Rubinstein. The network helps show where Ariel M. Rubinstein may publish in the future.

Co-authorship network of co-authors of Ariel M. Rubinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel M. Rubinstein. A scholar is included among the top collaborators of Ariel M. Rubinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel M. Rubinstein. Ariel M. Rubinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Awanish, Ariel M. Rubinstein, Jawad Abu-Tair, et al.. (2025). Effective head and neck cancer treatment combines radiation and local extended cisplatin release. Journal of Controlled Release. 384. 113923–113923.

Hermano, Esther, et al.. (2023). Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase. Biomedicines. 11(3). 710–710. 1 indexed citations

Flashner-Abramson, Efrat, et al.. (2022). Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes. Theranostics. 12(3). 1204–1219. 11 indexed citations

Rubinstein, Ariel M., Efrat Flashner-Abramson, Zvi Granot, et al.. (2022). Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance. Genome Medicine. 14(1). 120–120. 14 indexed citations

Hermano, Esther, Amir Sonnenblick, Ofra Maimon, et al.. (2022). Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma. Cells. 11(18). 2844–2844. 8 indexed citations

Salmon‐Divon, Mali, Roberto Salgado, Michael Elkin, et al.. (2021). Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. npj Breast Cancer. 7(1). 67–67. 17 indexed citations

Flashner-Abramson, Efrat, et al.. (2021). Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations. npj Precision Oncology. 5(1). 50–50. 17 indexed citations

Hermano, Esther, Françoise Carlotti, Amichay Meirovitz, et al.. (2020). Dichotomic role of heparanase in a murine model of metabolic syndrome. Cellular and Molecular Life Sciences. 78(6). 2771–2780. 4 indexed citations

Hermano, Esther, Rachel Goldberg, Ariel M. Rubinstein, et al.. (2019). Heparanase Accelerates Obesity-Associated Breast Cancer Progression. Cancer Research. 79(20). 5342–5354. 26 indexed citations

10.

Goldberg, Rachel, Amichay Meirovitz, Esther Hermano, et al.. (2019). Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma. Frontiers in Oncology. 9. 1405–1405. 5 indexed citations

11.

Rubinstein, Ariel M., et al.. (2016). Six3 regulates optic nerve development via multiple mechanisms. Scientific Reports. 6(1). 20267–20267. 15 indexed citations

12.

Lerner, Immanuel, Eyal Zcharia, Tzahi Neuman, et al.. (2013). Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice. Cellular and Molecular Life Sciences. 71(12). 2347–2357. 16 indexed citations

13.

Goldberg, Rachel, et al.. (2013). Versatile role of heparanase in inflammation. Matrix Biology. 32(5). 234–240. 113 indexed citations

14.

Goldberg, Rachel, Tzahi Neuman, Marjolein Garsen, et al.. (2011). Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice. Diabetes. 61(1). 208–216. 164 indexed citations

15.

Lerner, Immanuel, Esther Hermano, Eyal Zcharia, et al.. (2011). Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. Journal of Clinical Investigation. 121(5). 1709–1721. 163 indexed citations

16.

Rubinstein, Ariel M., Nikolaos Grigoriadis, Shlomo Nedvetzki, et al.. (2007). CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. Journal of the Neurological Sciences. 258(1-2). 17–26. 14 indexed citations

17.

Oberman, Froma, et al.. (2007). VICKZ proteins mediate cell migration via their RNA binding activity. RNA. 13(9). 1558–1569. 27 indexed citations

18.

Shpilberg, Ofer, et al.. (1990). Lipid profile in trained subjects undergoing complete food deprivation combined with prolonged intermittent exercise. European Journal of Applied Physiology. 60(4). 305–308. 7 indexed citations

19.

Rubinstein, Ariel M., et al.. (1989). Non-symmetric subcutaneous lipomatosis associated with familial combined hyperlipidaemia. British Journal of Dermatology. 120(5). 689–694. 18 indexed citations

20.

Das, Kiron M., et al.. (1976). In vivo and in vitro effect of sulfasalazine on lymphocyte in inflammatory bowel disease (IBD); systemic immunological parameters in idiopathic proctitis (IP). Gastroenterology. 70. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact